longitudinals lacking (lola) is among the most complex genes in Drosophila melanogaster, encoding up to twenty protein isoforms and acting as a key transcription factor in axonal pathfinding and neural reprogramming. Most of previous studies employed loss-of-function alleles disrupting common exons of lola, making it difficult to delineate its functions. To address this issue we have generated specific mutations in each isoform using the CRISPR/Cas9 system. Our targeted screen allows us to revisit the previously demonstrated roles for few isoforms and to demonstrate a specific function for one variant in axon guidance via activation of the microtubule-associated factor Futsch. Importantly, we also reveal a critical role for a second variant in preventing neurodegeneration via the control of the octopaminergic pathway. This variant is expressed almost exclusively in the octopaminergic cells and is involved in the transcriptional activation of a key enzyme of the pathway. Thus, our comprehensive study greatly expands the functional repertoire of Lola functions, and adds novel insights into the transcriptional regulatory control of neurotransmitter expression in vivo.
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Introduction
Size comparison of the human genome with the genome of lower organisms such as C. elegans or D. melanogaster predicts that the complexity of higher organisms does not simply rely on gene number [1] . Additional regulatory layers such as RNA editing, usage of multiple transcription start and termination sites as well as alternative pre-mRNA splicing (AS) are essential post-transcriptional mechanisms involved in the control of gene expression [2] . AS increases the number of proteins generated from a single pre-mRNA and is therefore one of the most important mechanisms to expand protein diversity.
However, while the existence of cell-type specific splicing patterns is well documented there is still relatively little knowledge about the contribution of specific isoforms during differentiation or in the functionality of a given cell.
lola is among the most complex loci in Drosophila giving rise to at least 80 different mRNA isoforms through alternative cis-and trans-splicing as well as via multiple promoter activity ( Figure 1A ) [3] [4] [5] [6] . In total, lola encodes 20 known protein isoforms (Lola A -Lola T) that contain a constitutive N-terminal BTB domain, with 17 isoforms encoding a unique zinc finger motif in their C-terminal variable exons ( Figure 1B ). Lola has been shown to act as a transcription factor with regulatory roles in axon growth and guidance during embryogenesis and is also required for maintaining neurons in a differentiated state by ensuring the continued repression of neural stem cells genes in neurons of the developing brain [3, 7, 8] . In addition to its described role during nervous system development, Lola has been found to control stem cell maintenance and germ cell differentiation in the Drosophila testis, programmed cell death during oogenesis and gonad formation in early embryo [9] [10] [11] .
Most experiments aimed to investigate Lola functions were performed using loss of function alleles containing mutations in the N-terminal constitutive region, which affect all 20 Lola isoforms and give pleiotropic effects in vivo [3, 4, 7, 8, 10, [12] [13] [14] [15] [16] [17] . Studies of specific isoform-mutant alleles, which are available only for Lola-K, -J, -L, and -T, revealed functions in distinct physiological processes [3, [9] [10] [11] 18] . Isoforms Lola-K and Lola-L are both involved in two unrelated mechanisms, which include motor-nerve development and germline stem cell maintenance in the male testis, indicating that at least some Lola isoforms control multiple functions during development [3, 10] .
Previous studies using RNA interference (RNAi) to assess functions of individual Lola isoforms regarding neural stem cell (NSC) proliferation in the Drosophila brain gave contradictory results [8, 19] . Additional work demonstrated extensive and significant offtargets for RNAi experiments in Drosophila, underlining the importance of a permanent and specific gene knock out, in which off-targets can be evaluated [20] . Recent cuttingedge development in genome engineering now enables precise genomic manipulation by making use of the CRISPR/Cas9 technique, a system that allows to permanently alter specific DNA regions of interest [21] [22] [23] .
In order to functionally characterize Lola isoforms we have performed a targeted loss-offunction screen using the CRISPR/Cas9 approach to specifically modify the lola locus in vivo. We generated loss-of-function mutations for each of the 20 known lola isoforms by respectively targeting the isoform-specific C-terminal exons. We found that amongst the 20 lola isoform-mutant strains, five are homozygous lethal during early development while three exhibit clear defects in adult flies. We confirm the previously observed lethality for the depletion of Lola-K, -L and T. Besides, we demonstrate that mutations targeting lola-F, in contrast to the other isoforms, result in severe disruption of axonal tracts at the ventral midline of embryos. This indicates that Lola-F is responsible for the characteristic axonal guidance phenotype observed under the complete loss of Lola. Lola-F regulates the expression of several axonal guidance genes, including the microtubule-associated factor Futsch. Remarkably, restoring Futsch expression is sufficient to rescue the axonal guidance phenotype of lola-F mutants, demonstrating that it is a critical target in the control of this process. Furthermore, flies bearing loss-of-function mutations for lola-A and lola-H display severe locomotion phenotypes. Finally, lola-O mutant flies are viable but display a strong degeneration phenotype due to a defective octopaminergic pathway. Octopamine is a critical neurotransmitter in invertebrates related to the vertebrate norepinephrine. Both octopamine and norepinephrine control diverse aspects of organismal behavior including aggressiveness, muscle activity, response to acute stress, learning and memory [24, 25] .
Like other neurotransmitter their levels need to be tightly controlled. We found that Lola-O is specifically expressed in the subset of neurons that produce octopamine and regulates its biogenesis by controlling the expression of Tyramine beta-hydroxylase (Tbh), which encodes a key enzymatic component of this pathway. Together, our data provides a comprehensive functional characterization of Lola isoforms, revealing novel roles for previously uncharacterized isoforms, including an unexpected function for one variant in neurotransmitter biogenesis.
Results

CRISPR/Cas9-induced lola isoform-specific knock-out
In order to comprehensively characterize Lola isoforms in vivo we sought to systematically generate knock out (KO) flies for each isoform using the CRISPR/Cas9 system. Briefly, two distinct guide RNAs (gRNAs) were designed to target the isoform-specific C-terminal exon of each lola isoform ( Figure 1C ). After establishment of transgenic lines expressing each pair of gRNAs, these flies were crossed with flies expressing Cas9 in the germline.
Specific modifications in the DNA of F1 flies were screened by PCR using primers spanning the flanking sequences targeted by the gRNAs, and followed by sequencing of the amplified DNA. In most cases, Cas9 activity resulted in the production of two doublestrand breaks, leading to deletion of the sequence between the two Cas9 target sites and resulting in a loss-of-function mutation for the respective lola isoform (Figures 1D and Figure S1 ).
Our targeted screen resulted in the production of KO flies for all 20 known Lola isoforms.
We found that mutations in 8 of these isoforms display a clear phenotype (Table 1) . Five isoform-specific mutations, including in the already described lola-K, -L, and T as well as in lola-F and -N, result in lethality during embryonic and early larval stages. Mutations in lola-A and -H produce viable flies but they have impaired locomotion in however opposite directions ( Figure S2A ). While the disruption of lola-H leads to reduced locomotion, lola-A mutant flies are hyperactive. Finally, lola-O mutants survive until adulthood but rapidly degenerate and die around two weeks after hatching. With the exception of Lola-H and -A, we found that only the isoforms that are conserved between D. melanogaster and Anopheles gambiae play important roles during development and in adults (Table 1) , raising the question of the relevance of the non-conserved Lola isoforms.
Among them, Lola-B was previously shown to play a critical role in NSC differentiation using RNA interference [19] . Upon depletion of Lola-B, proliferation of NSC was shown to be drastically reduced. However, our lola-B mutant flies do not recapitulate this phenotype, suggesting that this effect was likely due to off-target activity ( Figure S2B ). In contrast, mutations in the conserved lola-L and -K reproduce the reported defects in the innervation of ISNb motoneurons ( Figure S2C ), as well as the loss of lola-T in germ cell migration ( Figure S2D ). Note that the possible functional redundancy between different isoforms might prevent us to uncover additional roles for Lola. Consistent with this, reducing the level of both Lola-L and Lola-F was recently shown to alter NSC number, while reduction of either one alone has no effect [26] . In the next sections, we focus on the role of Lola-F and Lola-O, whose complete loss of function has not been previously characterized.
Lola-F is the main isoform required for axon guidance in the developing embryo
We generated two different lola-F alleles that are both lethal during late embryogenesis (Figures 1D, 2A and S1). One allele specifically lacks the zinc finger motif (lola-F znf ), whereas the second one carries a 2-bp deletion downstream of the zinc finger domain (lola-F stop ), leading to a frameshift and premature stop codon. We confirmed the specific depletion of Lola-F protein in both homozygous mutant embryos while the overall levels of other isoforms remain virtually unchanged ( Figure 2A ). Immunostaining using a Lola-F specific antibody further confirmed the absence of Lola-F protein in lola-F Stop mutant embryos ( Figure 2B ). Moreover, expression of a lola genomic construct rescues the lethal effect of both mutants, confirming the specificity of our loss of function alleles (data not shown). Expression analysis by in situ hybridization reveals a strong enrichment of lola-F mRNA in the developing CNS, which is lost in lola-F znf mutant embryos ( Figure 2C To address the role of Lola-F, we stained control and lola-F mutant embryos with anti-Fasciclin II to label axon tracts of stage 15 embryos ( Figure 2D ). The loss of all Lola isoforms was previously shown to strongly alter axonal growth and pathfinding at the ventral midline, a phenotype that we could recapitulate using the null lola E76 mutant allele.
Remarkably, depletion of Lola-F also results in severe disruption of the ventral nerve cord (VNC). Compared to the null mutant axons extend a bit further but several crossing defects were observed. The number of neurons, NSCs or glial cells is, however, unaffected ( Figures S3B and S3C ). Both alleles as well as transheterozygous combinations give indistinguishable phenotypes ( Figure 2D and data not shown). Moreover, expression of a lola-BAC was sufficient to rescue the axonal guidance defects (data not shown), confirming the specific role of this isoform in this process. We further generated a transgenic line expressing Lola-F under the control of UAS promoter. Strikingly, neuronal expression of this construct in wild type embryos strongly disrupts the VNC, mimicking the lola-F loss of function phenotype ( Figure 2D ). However, ubiquitous or neural expression of Lola-F cDNA in lola-F mutant embryos completely restores the axonal guidance defects ( Figure 2D and data not shown). Altogether these data indicate that Lola-F plays a major role in establishing proper axonal guidance at the ventral midline and suggest that its physiological levels must be tightly controlled to ensure correct function.
We next wondered whether other isoforms that are essential during embryonic development were also involved in controlling axon pathfinding at the midline. Lola-K and -L were already shown to control muscle innervation by ISNb motoneurons. We could recapitulate this phenotype and also demonstrate that Lola-F plays a similar function ( Figure S2C ). However, neither the depletion of Lola-K and -L nor the absence of Lola-N and -T alter axon guidance at the ventral midline ( Figure S2E ). Only lola-K mutants display occasionally crossing defects between the A5 and A6 hemisegments. Hence, our data indicate that Lola-F is the major isoform required in axonal pathfinding at the ventral midline for which lola is named for.
Lola-F activates expression of several genes involved in axon guidance
Previous studies reported the involvement of Lola in axon guidance in part by upregulating the levels of the repulsive ligand Slit and its receptor Robo at the ventral midline [15] , while its effect on axon growth could be partly explained by downregulation of the actin nucleation factor Spire [16] . To get further insights into the mechanisms by which Lola controls axon growth and guidance, we took advantage of our specific lola-F allele to perform a transcriptome analysis of lola-F mutant embryos at stage 15, when majority of axon growth and guidance events are taking place. We also included samples from lola null mutant embryos to compare the affected genes with the absence of lola-F. We found that 465 genes and 586 genes were significantly up-, and down-regulated in lola-F mutant embryos, respectively (adjusted P-value <0.01). Intriguingly, GO term analysis revealed enrichment for genes involved in cell adhesion and axon extension specifically for downregulated genes, underlining the role of Lola-F in regulating axogenesis ( Figure 3A and Figure S4A ). 217 (37 %) down-regulated genes are mutually found in the lola null mutant, including the previously described targets slit and robo1 (Figures 3A, 3B and Figures S4B,  S4C ). However, in contrast to the null allele, lola-F mutant shows no significant change in spire expression ( Figure 3B and Figure S4D ), indicating that other isoforms must control its level. The absence of spire regulation by Lola-F might account for the milder effect observed on axon growth in comparison to the complete loss of lola ( Figure 2D ). Furthermore, potential antagonistic isoform-specific Lola functions might nullify each other's effect, thus explaining that a subset of genes affected in the lola-F mutant is not present in the null allele.
Among the top 15 down-regulated genes that are common in both lola null and lola-F mutants is futsch, a well characterized and conserved axon guidance gene ( Figure 3A ). The axonal defects we observed for lola-F mutant embryos mimics the previously characterized futsch K68 mutant phenotype, as embryos show disrupted VNC motoraxons as well as stalling of the peripheral ISNb motornerve (Hummel et al., 2000, Figure S2C ). The reduction in transcript levels was confirmed by qRT-PCR and in situ hybridization (Figures 3C, 3D and 3E). Furthermore, immunostaining on lola-F KO embryos using a specific anti-Futsch antibody showed an overall reduced fluorescent intensity, indicating that the protein level was also decreased ( Figure 3E ). To examine whether the effect on futsch expression in the absence of Lola-F activity contributes to the observed phenotypes, we wondered whether restoring its levels could rescue some of the lola defects. To this purpose, we used an EP element insertion line containing UAS regulatory elements located in the promoter region of futsch that we crossed with the neuronal Elav-Gal4 driver line (see methods). We found that embryonic progeny derived from this cross display ectopic Futsch levels ( Figure S4E ). Similar elevated Futsch levels were observed in embryos deficient for Lola-F. Remarkably, this ectopic Futsch expression was sufficient to partially restore both VNC and ISNb axonal defects ( Figure 3F and Figure S4F ). Taken together, our findings demonstrate that Lola-F regulates axonal pathfinding by activating the expression of numerous axon guidance genes during embryogenesis including the microtubule associated encoded gene futsch.
lola-O mutant flies display a severe degeneration phenotype
We next investigated the function of Lola-O in vivo. We generated one mutant allele that is expected to disrupt the entire zinc finger domain ( Figure 4A ). The lack of mRNA expression was confirmed by qRT-PCR and RNA sequencing using RNA extracts from Figure S5H ). In contrast, glial expression has no effect ( Figure   4F ). Taken together, these findings indicate a neuronal role for Lola-O in regulating multiple physiological functions.
lola-O is specifically expressed in octopaminergic neurons
In order to obtain insights into Lola-O function, we seek to address its localization in vivo.
For this purpose we took advantage of a fly line carrying a lola-BAC encoding a Lola-O-GFP fusion protein (Spokony & White, 2012). We found that Lola-O is generally expressed at a very low level in the larval brain, just at the limit of its detection. However, the low Lola-O-GFP expression is refined to only a subset of cells, which includes the midline and lateral midline of the ventral ganglion and few groups of cells in the central brain ( Figure 5A ). In order to reveal the identity of these cells we crossed flies carrying a UAS-GFP transgene reporter with flies expressing GAL4 under the control of various promoters, which are active in the brain. The resulting GFP expression was subsequently compared to the expression pattern of Lola-O. Interestingly, GFP expression driven by the Tdc2-GAL4 driver was reminiscent to the expression of Lola-O-GFP ( Figure 5B ).
Tdc2 stands for Tyrosine-decarboxylase and encodes for an enzyme required for the synthesis of octopamine ( Figures 5B, 6A ). Octopamine acts as a neurotransmitter, neuromodulator and neurohormone in insects and is involved in diverse physiological functions. Interestingly, perturbation of its level results in phenotypes reminiscent to the loss of Lola-O, including locomotion defects, cuticle deformity, appearance of pseudotumors and female sterility [27] [28] [29] . Its synthesis requires the amino acid tyrosine, which is modified to the intermediate compound tyramine by the enzyme Tyrosinedecarboxylase 2 (Tdc2). Subsequently, Tyramine β-hydroxylase (TBH) hydrolyzes tyramine to synthesize the neurotransmitter octopamine ( Figure 6A and [30] . Noticeably, we found that mutant flies for Tbh (Tbh nM18 ) displayed impaired longevity, implying a previously uncharacterized role for octopamine on survival ( Figure S6 ).
To confirm the expression of Lola-O in octopaminergic neurons, larval brains were stained for both Lola-O-GFP and an antibody that recognizes TΒΗ as TBH expression was shown to be a faithful marker of octopaminergic neurons [31] . We found that TBH and Lola-O-GFP co-localize in a cluster of dorso-medial cells in the larval brain and along the midline of the VNC. Single cells lateral of the midline are however only positive for Lola-O-GFP ( Figure 5C ). Therefore, our data suggest that Lola-O function may be linked to the octopaminergic pathway.
Expression of lola-O cDNA in octopaminergic neurons is sufficient to rescue most of
lola-O mutant defects
To address a potential role of Lola-O in the octopaminergic pathway, we performed a drug-feeding assay in which lola-O mutant flies were supplied with octopamine-enriched food. Interestingly, ectopic feeding of octopamine to lola-O mutants was sufficient to elongate the half-life by twofold (12 days +/-2.6 versus 21 days +/-3.6, p-value <0.5), while feeding the same flies with tyrosine had no effect ( Figures 6B and 6C ). We verified that feeding Tßh nM18 mutant flies with octopamine rescues the half-life to a similar extent ( Figure S6 ). Furthermore, octopamine-enriched food improves locomotion of lola-O mutants and reduces the occurrence of pseudotumors close to wild type levels (9,86% on octopamine-enriched food compared to 85,71 % on control food) ( Figures 6D and 6E ).
Therefore, these results strongly suggest that the defects observed in lola-O mutant flies result from reduced levels of octopamine.
We reasoned that if Lola-O function was solely required in octopaminergic cells, expressing Lola-O specifically in these cells should be sufficient to rescue all defects associated with its loss. To test this hypothesis, we used the Tdc2-GAL4 driver, which is specific for octopaminergic cells. Crossing this driver line with UAS-Lola-O flies completely restores the survival of lola-O mutants as well as their climbing ability and the appearance of pseudotumors ( Figures 7A, S7A and S7B ). Furthermore, the fertility of mutant flies was also partially rescued as evidenced by the improved egg-laying rate ( Figure S7C ). Altogether these experiments demonstrate that Lola-O primary activity is restricted to octopaminergic neurons.
Lola-O regulates the octopaminergic pathway via the control of Tbh expression
Octopamine is synthetized via the activity of two enzymes, Tdc2 and TΒΗ. To test whether Lola-O might control their expression in vivo, we analyzed transcript levels from RNA isolated from adult heads of control and lola-O mutant flies using qRT-PCR. Intriguingly, while Tdc2 expression is unaffected in lola-O mutants, the level of Tbh mRNA is significantly reduced ( Figure 7B ). A similar result was observed in a transheterozygous combination in which lola-O mutant was crossed with a lola deficiency line (data not shown). We also found that TΒΗ protein level is decreased as shown by reduced TΒΗ immunoreactivity in brains of lola-O mutant larvae ( Figure S7D ). The specificity of the TBH staining was confirmed, as the signal was essentially absent in brains of Tbh mutant larvae ( Figure S7E ). Collectively, these results indicate that Lola-O is required to maintain proper Tbh levels.
Given the reduced abundance of Tbh in lola-O mutants we wondered whether ectopic expression of Tbh cDNA would be sufficient to restore longevity and phenotypic penetrance of these flies. We generated flies with integrated Tbh under the control of a UAS-promoter and induced expression using different GAL4-lines. Remarkably, expression of Tbh using a neuronal specific driver line was sufficient to rescue fly survival and to significantly decrease the occurrence of pseudotumors ( Figures 7C, 7D) . These findings therefore demonstrate that Tbh is the primary target of Lola-O in the octopaminergic pathway.
To address whether Tbh might be directly regulated by Lola-O we aimed to identify Lola-O genome-wide binding sites. For this purpose we took advantage of the recently established targeted DamID (TaDa) approach, which allows identifying direct target genes in a cell-type specific manner [32] . We cloned lola-O coding sequence into pUASTattB-LT3-NDam to allow the targeted, low-level, expression of N-terminally tagged Dam-Lola-O. We then induced neuronal Dam-Lola-O expression in embryos using the driver line elav-Gal4 and processed them at stage 17, just before larval hatching [33] . The TaDa experiment was performed in biological duplicates, showing a high degree of correlation between the two samples (r = 0.94). Consistent with Tbh being a direct target of Lola-O, we found that Lola-O binds Tbh at 5', intronic and 3' regions ( Figure 7E ), with the most significant event having a false discovery rate (FDR) of 2 x 10 -5 . Despite the specific function of this factor, Lola-O binds widely throughout the genome, with the potential to regulate about half of all genes (9158 genes identified with a FDR of < 0.01). This may reflect the potential for Lola-O to regulate different sets of genes in different tissues and/or its ability to heterodimerise with other Lola isoforms.
Discussion
Here, we describe for the first time a comprehensive functional characterization of the different Lola isoforms in vivo. Using the CRISPR/Cas9 approach we generated mutants for every lola isoform and demonstrated that mutation in lola-F mimics the characteristic lola null mutant phenotype during embryogenesis. We further uncovered an unexpected function for Lola in the octopaminergic pathway mediated by Lola-O activity via the activation of Tbh. In addition to revealing novel Lola functions, this study demonstrates that the recently developed CRISPR/Cas9 system can be used to systematically address isoform-specific functions in vivo.
Assigning Lola function to specific isoforms
Lola is amongst the most complex loci in Drosophila, encoding for 20 different protein isoforms via the usage of 3' alternative exons. Its complete loss of function gives rise to pleiotropic defects in vivo, which have been difficult to analyze at the molecular level due to the paucity of specific mutant isoforms. First described in 1993 by Giniger and colleagues, Lola was shown to control axon growth and guidance in both the CNS and PNS of the Drosophila embryo. However, it remained unclear how it exerts these functions, and whether these effects depend on a specific Lola isoform or on the activities of multiple ones. Our results clearly establish Lola-F as being the main isoform required in these early developmental processes. A previous transcriptomic analysis from lola-null mutant extracts revealed only small changes on gene expression, suggesting that Lola controls axonal guidance by fine-tuning the expression of many genes involved in this process, and it is the sum of small changes on many genes that give rise to the severe lola null mutant phenotype [16] . Nevertheless, several key targets could be identified. For instance, in the CNS, Lola was suggested to repel longitudinal axons away from the midline through increasing the expression of the midline repellant Slit and its axonal receptor Robo [15] . In the PNS, Lola controls ISNb axonal growth partially via reducing the expression of the actin nucleation factor Spire [16] . In spite of Lola-F being involved in both processes, we found that only slit and robo expression was altered, while spire was unchanged. Furthermore, our study revealed futsch as being a key target of Lola-F in axon growth. Futsch is a microtubule-associated protein whose expression levels need to be tightly controlled. For instance, heterozygous animals display mutant phenotypes, including slower growth rates and motor system abnormalities, indicating that its dosage is critical for its function [34] . Moreover, its expression in the somatic and visceral musculature is repressed by Tramtrack [35] . It is interesting to note that Tramtrack, like Lola, encodes for a zinc finger and BTB-domain containing protein, suggesting that this class of proteins plays a prominent role in either repressing or activating Futsch expression.
Previous studies on several BTB-containing proteins demonstrated that the BTB domain mediates homomeric and heteromeric dimerization, and transcriptional repression through the recruitment of diverse co-repressor proteins [36, 37] . Our data, however, indicates that Lola-F is a general activator of neuronal genes. Further interactome studies will therefore be necessary to understand how different BTB proteins exert antagonistic molecular functions on gene expression.
Interestingly, the expression of Lola-F drops as Drosophila development progresses and
becomes primarily restricted to NSCs. This finding suggests that neuronal gene expression outside the NSCs must be maintained by different means, such as via the activity of other transcription factors or via an epigenetic mechanism. Intriguingly, Lola-F was shown to interact early in development with the histone H3S10 kinase JIl-1 [6] . Via this molecular activity, JIL-1 maintains euchromatic regions by antagonizing Su(var)3-9-mediated heterochromatinization. Therefore, it is possible that early during development, Lola-F establishes an epigenetic state compatible with gene expression via its association with JIL-1 and once established, its function might become dispensable. The remaining Lola-F expression in NSCs appears important to maintain their differentiation capacity as the double KD of Lola-F and Lola-L leads to dramatic overprofileration of NSCs in the central brain [26] . It will be important to further identify the direct targets of Lola-F and Lola-L in this process to understand how these two isoforms cooperate to allow NSC differentiation.
Novel connection between Lola and the octopaminergic pathway
Our study also revealed a novel role for Lola in the octopaminergic pathway. This function was probably missed due to pleitotropic effects of lola null mutants combined with the lack of specific lola-O alleles. Our findings demonstrate a regulatory role for Lola-O in the octopaminergic pathway by activating Tbh expression, which encodes an enzyme required for the synthesis of octopamine, a monoamine that acts as a neurohormone neuromodulator as well as neurotransmitter [38] . Monoamine neurotransmitter levels are usually tightly regulated, as their misregulation can lead to a wide range of disorders in human [39] .
Accordingly, several evidences indicate that the absolute levels of octopamine must also be tightly controlled. For instance, reducing its levels in a Tbh mutant leads to diverse defects, including female sterility, locomotion, aggressiveness and pseudotumor formation [24, 27, 28] . On the other hand, increasing its level also leads to similar abnormalities [29] . Despite this dosage-function dependency, very little is known about the mechanisms controlling octopamine synthesis during different stages of the Drosophila life cycle. Studies on honeybees have shown that octopamine synthesis increases with age [40] , which might be also the case in Drosophila. Additionally, octopamine synthesis has been shown to be stress-induced in the haemolymph in both locusts and cockroaches [41] , implying that differential concentrations of octopamine are required in response to altered environmental circumstances. Recent reports also demonstrated an increase in octopamine metabolism upon heat conditions in Drosophila, which is mediated via FOXO activity [42] . It would therefore be interesting to test whether TBH expression is also stress-induced and whether Lola-O contributes to this effect.
Future Directions
Our studies illuminate a novel role for Lola in controlling neurotransmitter signaling. Obtained PCR amplicons were purified and sequenced at GATC Biotech.
UAS constructs
Coding sequences of lola-O, lola-F and Tbh was amplified from cDNA using Phusion High 
Fertility assay
10 female virgin flies were separated upon hatching and mated with 5 males for three days.
Upon fertilization, flies were transferred onto fresh agar plates every twelve hours. Number of eggs laid was counted for five days. Experiments were performed in three biological replicates.
Transcriptome analysis
Collection of lola mutant embryos: Embryos were collected at 25°C for two hours and subsequently developed for 13 hours. lola-F FS and lola E76 embryos were hand-sorted and collected based on the expression of mCherry. Control embryos were collected in parallel and both mutant and control embryos were subsequently transferred into TRIzol reagent (Thermo Fisher Scientific) and RNA was isolated using the manufacturers protocol.
Collection of lola-O mutant adult flies: 20 males of either lola-O mutant or control flies were collected within 10 hours of eclosion, transferred into TRIzol reagent and subjected to RNA isolation.
cDNA library preparation
RNA was isolated, DNase I (NEB) treated according to the manufacturers protocol and subjected to library preparation using the NEBNext® Ultra™ Directional RNA Library Prep Kit for Illumina®. 1 µg of total RNA was used as starting material for library preparation.
cDNA libraries were subsequently submitted for high throughput sequencing on a HiSeq2500.
Computational analysis
Libraries for transcriptome analysis were sequenced in two different sequencing runs on a (Marshall and Brand, 2016) . Peaks were called and mapped to genes using a custom Perl program (available on request). In brief, a false discovery rate (FDR) was calculated for peaks (formed of two or more consecutive GATC fragments) for the individual replicates. Then each potential peak in the data was assigned a FDR. Any peaks with less than a 1% FDR were classified as significant.
Significant peaks present in both replicates were used to form a final peak file. Any gene within 5 kb of a peak (with no other genes in between) was identified as a potential target gene.
qRT-PCR
Total RNA was prepared and transcribed into cDNA using MMLV reverse transcriptase (Promega). For the measurement of RNA levels qRT-PCR analysis was performed using a ViiA7 real-time PCR system (Applied Biosystems). Measurements were done in triplicates.
Relative RNA levels were normalized to rpl15 levels. Primer sequences are listed in Supplemental Tables.
In situ hybridization
Preparation of digoxigenin-labeled RNA probes: primers were designed to amplify a unique region within lola exons with the reverse primer containing the SP6 sequence. 
Western blotting
For western blot analysis, staged embryos of the corresponding genotype were collected and For comparisons of the means of two groups, student's t-test was used. For comparisons among more than two groups the one-way ANOVA was performed followed by multiple comparisons using t-tests with Bonferroni normalization of p-values. WT 
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